Massachusetts Financial Services’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-123,362
| Closed | -$1.23M | – | 868 |
|
|
2019
Q2 | $1.23M | Buy |
123,362
+17,188
| +16% | +$172K | ﹤0.01% | 775 |
|
|
2019
Q1 | $1.37M | Buy |
106,174
+3,927
| +4% | +$50.6K | ﹤0.01% | 760 |
|
|
2018
Q4 | $1.55M | Buy |
102,247
+7,959
| +8% | +$121K | ﹤0.01% | 728 |
|
|
2018
Q3 | $1.89M | Sell |
94,288
-220
| -0.2% | -$4.4K | ﹤0.01% | 721 |
|
|
2018
Q2 | $1.84M | Buy |
94,508
+12,944
| +16% | +$252K | ﹤0.01% | 720 |
|
|
2018
Q1 | $1.64M | Buy |
81,564
+1,485
| +2% | +$29.9K | ﹤0.01% | 713 |
|
|
2017
Q4 | $1.06M | Buy |
80,079
+11,051
| +16% | +$146K | ﹤0.01% | 757 |
|
|
2017
Q3 | $1.27M | Sell |
69,028
-1,030
| -1% | -$19K | ﹤0.01% | 721 |
|
|
2017
Q2 | $1.29M | Buy |
70,058
+2,017
| +3% | +$37.1K | ﹤0.01% | 738 |
|
|
2017
Q1 | $1.53M | Buy |
68,041
+810
| +1% | +$18.3K | ﹤0.01% | 721 |
|
|
2016
Q4 | $2.34M | Sell |
67,231
-401,485
| -86% | -$14M | ﹤0.01% | 709 |
|
|
2016
Q3 | $11.5M | Buy |
468,716
+32,538
| +7% | +$797K | 0.01% | 558 |
|
|
2016
Q2 | $10.4M | Sell |
436,178
-29,914
| -6% | -$716K | 0.01% | 565 |
|
|
2016
Q1 | $10.9M | Buy |
466,092
+433
| +0.1% | +$10.1K | 0.01% | 568 |
|
|
2015
Q4 | $14.1M | Sell |
465,659
-566,985
| -55% | -$17.1M | 0.01% | 552 |
|
|
2015
Q3 | $41M | Sell |
1,032,644
-142,661
| -12% | -$5.67M | 0.02% | 369 |
|
|
2015
Q2 | $81.2M | Sell |
1,175,305
-277,843
| -19% | -$19.2M | 0.04% | 280 |
|
|
2015
Q1 | $79.4M | Buy |
1,453,148
+1,146,774
| +374% | +$62.7M | 0.04% | 280 |
|
|
2014
Q4 | $13.1M | Buy |
+306,374
| New | +$13.1M | 0.01% | 595 |
|